Graziana Barile
Research Subjects
Graziana Barile has a total of 138 co-authors. Here are the top co-authors by number of shared publications:
Angela Pezzolla
Azienda Osped Univ Consorziale Policlin Bari, Unita Operat Semplice, Dipartimentale Chirurg Videolaparoscop Urgenza, Dipartimento Emergenza & Trapianti Organo, Bari, Italy
3 shared publications- Serafina Lattarulo
Department of Emergency and Organ Transplant - Minimally invasive and Endocrine Surgery Unit, University Medical School of Bari, Bari, Italy
3 shared publications Daniele Paradies
Azienda Osped Univ Consorziale Policlin Bari, Unita Operat Semplice, Dipartimentale Chirurg Videolaparoscop Urgenza, Dipartimento Emergenza & Trapianti Organo, Bari, Italy
2 shared publications- Francesco Paolo Prete
Department of Precision and Regenerative Medicine and Ionian Area (DiMePreJ), Aldo Moro University, Bari, Italy
2 shared publications Michele Simone
2 shared publications- Raffaele De Luca
Department of Surgical Oncology, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy
2 shared publications
Latest Publications
- 1 March 2020
- Published by Elsevier in Journal of Geriatric Oncology
- Vol. 11 (2) , 244-255
GOSAFE - Geriatric Oncology Surgical Assessment and Functional rEcovery after Surgery: early analysis on 977 patients
- 1 March 2020
- Published by Elsevier in Journal of Geriatric Oncology
- Vol. 11 (2) , 244-255
GOSAFE - Geriatric Oncology Surgical Assessment and Functional rEcovery after Surgery: early analysis on 977 patients
- 8 July 2019
- Vol. 8
An Intrapancreatic accessory spleen presenting as a neuroendocrine tumor.
Although the second most common site of the accessory spleen is the tail of the pancreas, intrapancreatic accessory spleens (IPAS) are rarely recognized radiologically. When an accessory spleen is located in the pancreas, it may mimic a hypervascular pancreatic tumor. We report a case of intrapancreatic accessory spleen which radiologically (on TC) mimicked a neuroendocrine pancreatic tumor (PNET). It was not possible to be sure that the pancreatic nodule had no malignant potential; because of the close proximity to splenic vessel we performed en bloc resection of the spleen and distal pancreas. Postoperative course was uneventful. IPAS must be considered in the differential diagnosis of pancreatic tail tumors, particulary an asymptomatic small PNET; new and adequate diagnostic studies have demonstrated utility in defining these lesions. We review pertinent literature. KEY WORD: Intrapancreatic accessory spleen, Pancreatic neuroendocrine tumor.
- 8 July 2019
- Vol. 8
An Intrapancreatic accessory spleen presenting as a neuroendocrine tumor.
Although the second most common site of the accessory spleen is the tail of the pancreas, intrapancreatic accessory spleens (IPAS) are rarely recognized radiologically. When an accessory spleen is located in the pancreas, it may mimic a hypervascular pancreatic tumor. We report a case of intrapancreatic accessory spleen which radiologically (on TC) mimicked a neuroendocrine pancreatic tumor (PNET). It was not possible to be sure that the pancreatic nodule had no malignant potential; because of the close proximity to splenic vessel we performed en bloc resection of the spleen and distal pancreas. Postoperative course was uneventful. IPAS must be considered in the differential diagnosis of pancreatic tail tumors, particulary an asymptomatic small PNET; new and adequate diagnostic studies have demonstrated utility in defining these lesions. We review pertinent literature. KEY WORD: Intrapancreatic accessory spleen, Pancreatic neuroendocrine tumor.
- Open Access
- 24 April 2019
- Published by Springer Nature in BMC Surgery
- Vol. 18 (S1) , 1-11
Transaxillary robotic-assisted thyroid surgery: technique and results of a preliminary experience on the Da Vinci Xi platform
Robotic thyroidectomy by transaxillary approach (RATS) is regarded as a feasible and safe alternative procedure in selected patients with benign disease or thyroid cancer of low risk, facilitating thyroidectomy with respect to conventional endoscopic approach and offering improved cosmetic results. The Da Vinci Xi surgical system (Intuitive Surgical, Sunnyvale, CA, USA) presents technical advantages over its previous generations, including overhead docking, more compact robotic arms, extended range of motion, and ability for camera to be docked in any arm. This construct supports dissection in smaller spaces with less arm interference and improved view. We present an initial experience of RATS on DVSS Xi in an academic Centre in Italy. We conducted a prospective observational study, involving patients with thyroid disease and treated between April 2016 and January 2018. A modified thyroidectomy retractor (Modena retractor, CEATEC Medizintechnik, Germany) was used to lift a musculocutaneous flap and operate gasless. Instrument placement was recorded for each procedure. Each procedure description was broken down into three phases, creation of working space, machine docking with instrument positioning and endoscopic operating technique. Duration of cases was recorded. Patients selected were young women, BMI < 30, thyroid nodule < 5 cm, cytology TIR2 to TIR4 (TIR4:only nodules < 1 cm diameter). Twelve RATS were performed within the learning curve for the robotic technique, 10 lobectomies and 2 total thyroidectomies. No patients required reintervention. Mean duration of surgery was 198.9 min for lobectomy and 210 for thyroidectomy. The same surgical team performed all procedures. No patients presented surgery-related complications, mean stay was 3 days. Decrease in operating time was observed after 8 cases along with more precise preparation of working space. Four arms were used in the first 10 procedures then only three. No recurrent laryngeal nerve dysfunction, no seroma or haematoma were recorded. One patient had transient hypocalcaemia after total thyroidectomy. Since the early phases of a preliminary experience RATS appeared a safe alternative to open thyroidectomy. Uptake of technique was quick on Xi platform with few technical tweaks over techniques described for Si machines. Careful patient selection is crucial. Retrospectively registered on 20 july 2018 . Trial registration number: researchregistry4272. The Research Registry: https://www.researchregistry.com/browse-the-registry#home/registrationdetails/5b517f08dbc2045aefd7f9b4/
- 24 April 2019
- Published by Springer Nature in BMC Surgery
- Vol. 18 (S1) , 1-11
Open AccessTransaxillary robotic-assisted thyroid surgery: technique and results of a preliminary experience on the Da Vinci Xi platform
Robotic thyroidectomy by transaxillary approach (RATS) is regarded as a feasible and safe alternative procedure in selected patients with benign disease or thyroid cancer of low risk, facilitating thyroidectomy with respect to conventional endoscopic approach and offering improved cosmetic results. The Da Vinci Xi surgical system (Intuitive Surgical, Sunnyvale, CA, USA) presents technical advantages over its previous generations, including overhead docking, more compact robotic arms, extended range of motion, and ability for camera to be docked in any arm. This construct supports dissection in smaller spaces with less arm interference and improved view. We present an initial experience of RATS on DVSS Xi in an academic Centre in Italy. We conducted a prospective observational study, involving patients with thyroid disease and treated between April 2016 and January 2018. A modified thyroidectomy retractor (Modena retractor, CEATEC Medizintechnik, Germany) was used to lift a musculocutaneous flap and operate gasless. Instrument placement was recorded for each procedure. Each procedure description was broken down into three phases, creation of working space, machine docking with instrument positioning and endoscopic operating technique. Duration of cases was recorded. Patients selected were young women, BMI < 30, thyroid nodule < 5 cm, cytology TIR2 to TIR4 (TIR4:only nodules < 1 cm diameter). Twelve RATS were performed within the learning curve for the robotic technique, 10 lobectomies and 2 total thyroidectomies. No patients required reintervention. Mean duration of surgery was 198.9 min for lobectomy and 210 for thyroidectomy. The same surgical team performed all procedures. No patients presented surgery-related complications, mean stay was 3 days. Decrease in operating time was observed after 8 cases along with more precise preparation of working space. Four arms were used in the first 10 procedures then only three. No recurrent laryngeal nerve dysfunction, no seroma or haematoma were recorded. One patient had transient hypocalcaemia after total thyroidectomy. Since the early phases of a preliminary experience RATS appeared a safe alternative to open thyroidectomy. Uptake of technique was quick on Xi platform with few technical tweaks over techniques described for Si machines. Careful patient selection is crucial. Retrospectively registered on 20 july 2018 . Trial registration number: researchregistry4272. The Research Registry: https://www.researchregistry.com/browse-the-registry#home/registrationdetails/5b517f08dbc2045aefd7f9b4/
- 1 March 2018
- Vol. 89 (2) , 113-117
Incidental thyroid carcinoma in patients with TIR1, TIR2 and TIR3 FNA
AIM: The aim of our study was to evaluate the presence of incidental differentiated thyroid carcinomas, at final histological examination, in patients undergoing thyroidectomy or lobectomy for presumed benign pathology or in those with cytological diagnosis of indeterminate nodules (TIR3). MATERIAL OF STUDY: 457 patients who underwent surgery for benign disease and 179 patients with indeterminate FNA were included in our study. RESULTS: 77 out of 457 patients had the diagnosis of differentiated thyroid carcinoma. 29 out of 179 patients had the same diagnosis as previous ones, but not on the undetermined FNA nodule. In the most of the cases, the istotype was follicular variant of papillary carcinoma. DISCUSSION: The incidence of incidental carcinomas, approximately the same in the two groups of patients, respectively 168% and 162%, shows that there is still a group of patients with benign thyroid disease escaping a careful ultrasound evaluation and therefore a targeted FNA. Even in patients with indeterminate cytology, the presence of an incidental carcinoma suggests that on the one hand there has been an overestimation and on the other a non-recognition of the really suspect nodule. Although in most cases it is a microcarcinoma, we must not overlook the presence of many tumors at stage T3. CONCLUSIONS: Surely the analysis of the set of risk factors with a wider application of molecular biology surveys will in the future lead to better selection of patients to undergo surgery sooner than those that can be followed in follow up even for a longer period of time.
- 1 March 2018
- Vol. 89 (2) , 113-117
Incidental thyroid carcinoma in patients with TIR1, TIR2 and TIR3 FNA
AIM: The aim of our study was to evaluate the presence of incidental differentiated thyroid carcinomas, at final histological examination, in patients undergoing thyroidectomy or lobectomy for presumed benign pathology or in those with cytological diagnosis of indeterminate nodules (TIR3). MATERIAL OF STUDY: 457 patients who underwent surgery for benign disease and 179 patients with indeterminate FNA were included in our study. RESULTS: 77 out of 457 patients had the diagnosis of differentiated thyroid carcinoma. 29 out of 179 patients had the same diagnosis as previous ones, but not on the undetermined FNA nodule. In the most of the cases, the istotype was follicular variant of papillary carcinoma. DISCUSSION: The incidence of incidental carcinomas, approximately the same in the two groups of patients, respectively 168% and 162%, shows that there is still a group of patients with benign thyroid disease escaping a careful ultrasound evaluation and therefore a targeted FNA. Even in patients with indeterminate cytology, the presence of an incidental carcinoma suggests that on the one hand there has been an overestimation and on the other a non-recognition of the really suspect nodule. Although in most cases it is a microcarcinoma, we must not overlook the presence of many tumors at stage T3. CONCLUSIONS: Surely the analysis of the set of risk factors with a wider application of molecular biology surveys will in the future lead to better selection of patients to undergo surgery sooner than those that can be followed in follow up even for a longer period of time.
- 1 November 2016
- Published by Edizioni Minerva Medica in Chirurgia
- Vol. 30 (1)
Adenocarcinomi del digiuno in maschi adulti con preesistenti malattie intestinali non neoplastiche
Article: Jejunal adenocarcinomas in male adults with pre-existing non-neoplastic disease - Chirurgia 2017 February;30(1):14-7 - Minerva Medica - Journals
- 1 November 2016
- Published by Edizioni Minerva Medica in Chirurgia
- Vol. 30 (1)
Adenocarcinomi del digiuno in maschi adulti con preesistenti malattie intestinali non neoplastiche
Article: Jejunal adenocarcinomas in male adults with pre-existing non-neoplastic disease - Chirurgia 2017 February;30(1):14-7 - Minerva Medica - Journals
- 1 August 2014
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 12, S98-S102
Incidental carcinoma of the thyroid
The diagnosis of incidental thyroid carcinoma in patients submitted to thyroidectomy for a benign disease is quite frequent. A retrospective analysis was performed on 455 patients submitted to surgical intervention in order to establish the incidence of this kind of carcinoma. Two hundred fifty-six patients (56%) were affected by benign disease (176 multinodular goiter, 12 uninodular goiter, 1 Plummer disease and 67 Basedow disease) and 202 (44%) by carcinoma. In 28 of 256 patients (11%), affected by benign disease, occurred a histological diagnosis of thyroid carcinoma, (10 papillary carcinoma, 1 follicular carcinoma, 29 papillary carcinoma follicular variant). In this study it's considered incidental thyroid carcinoma the one occurred in patients who never underwent Fine Needle Aspiration (FNA) and there were no suspicious features in all exams that may suggest the presence of carcinoma. Twenty-three of the 40 incidental carcinoma (57.5%) were microcarcinomas. Ten patients had a sincronous carcinoma. Actually, these patients are still in a follow up program and no recurrency of disease is occasionally observed. This study shows that the only way to put doubts on the real benignity of the disease is the fine needle aspiration; there are no other instruments that could identify the occurrence of the carcinoma. Moreover in the majority of cases the incidental carcinoma is a microcarcinoma, it doesn't reach significant volume, may be not centered by a FNA, but in most cases it's not really biologically aggressive.
- 1 August 2014
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 12, S98-S102
Incidental carcinoma of the thyroid
The diagnosis of incidental thyroid carcinoma in patients submitted to thyroidectomy for a benign disease is quite frequent. A retrospective analysis was performed on 455 patients submitted to surgical intervention in order to establish the incidence of this kind of carcinoma. Two hundred fifty-six patients (56%) were affected by benign disease (176 multinodular goiter, 12 uninodular goiter, 1 Plummer disease and 67 Basedow disease) and 202 (44%) by carcinoma. In 28 of 256 patients (11%), affected by benign disease, occurred a histological diagnosis of thyroid carcinoma, (10 papillary carcinoma, 1 follicular carcinoma, 29 papillary carcinoma follicular variant). In this study it's considered incidental thyroid carcinoma the one occurred in patients who never underwent Fine Needle Aspiration (FNA) and there were no suspicious features in all exams that may suggest the presence of carcinoma. Twenty-three of the 40 incidental carcinoma (57.5%) were microcarcinomas. Ten patients had a sincronous carcinoma. Actually, these patients are still in a follow up program and no recurrency of disease is occasionally observed. This study shows that the only way to put doubts on the real benignity of the disease is the fine needle aspiration; there are no other instruments that could identify the occurrence of the carcinoma. Moreover in the majority of cases the incidental carcinoma is a microcarcinoma, it doesn't reach significant volume, may be not centered by a FNA, but in most cases it's not really biologically aggressive.
- 1 December 2012
- Published by Il Pensiero Scientifico Editore in Recenti Progressi in Medicina
- Vol. 103 (12) , 578-580
Colecistectomia laparoscopica per colecistite acuta in gravidanza: il caso di una portatrice di situs viscerum inversus
Si descrive il caso di una donna al terzo mese di gravidanza (Fertilizzazione In Vitro con Embryo Tansfer – FIVET – esitata in gravidanza gemellare), portatrice di situs viscerum inversus totalis, giunta alla nostra osservazione per colecistite acuta litiasica. Optiamo per un approccio laparoscopico e la colecistectomia viene eseguita con successo senza morbilità alcuna su madre e feti.
- 1 December 2012
- Published by Il Pensiero Scientifico Editore in Recenti Progressi in Medicina
- Vol. 103 (12) , 578-580
Colecistectomia laparoscopica per colecistite acuta in gravidanza: il caso di una portatrice di situs viscerum inversus
Si descrive il caso di una donna al terzo mese di gravidanza (Fertilizzazione In Vitro con Embryo Tansfer – FIVET – esitata in gravidanza gemellare), portatrice di situs viscerum inversus totalis, giunta alla nostra osservazione per colecistite acuta litiasica. Optiamo per un approccio laparoscopico e la colecistectomia viene eseguita con successo senza morbilità alcuna su madre e feti.